{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_8207110_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefType":"PATENT","entityRefId":"100-914-901-367-480"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8759,"type":"PATENT","title":"University of Columbia","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":13487,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8203,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Searched applicants and Owners= \"Columbia Univ\", \"Univ Columbia\", \" Univ Colum*\", \"Colum* univ\", \"Univ* Colum* NOT British\".
Select more for logical Variants
Add to collection
Total patents: more than 10k
Searched applicants and Owners= \"Columbia Univ\", \"Univ Columbia\", \" Univ Colum*\", \"Colum* univ\", \"Univ* Colum* NOT British\".
Select more for logical Variants
Add to collection
Total patents: more than 10k
1. identifying a subject that has received an organ transplant, and\n
2. administering to the subject an immunosuppressive amount of a soluble polypeptide comprising the extracellular domain of human ILT3."],"number":1,"annotation":false,"title":false,"claim":true},{"lines":["The method of claim 1 wherein the subject has been diagnosed with transplant rejection."],"number":2,"annotation":false,"title":false,"claim":true},{"lines":["The method of claim 1, wherein the soluble polypeptide is operably affixed to the Fc portion of an immunoglobulin."],"number":3,"annotation":false,"title":false,"claim":true},{"lines":["The method according to claim 3, wherein said Fc portion comprises a function-enhancing mutation, wherein the mutation inhibits the binding of said Fc portion to an Fc receptor."],"number":4,"annotation":false,"title":false,"claim":true}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}